SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-025448
Filing Date
2021-12-21
Accepted
2021-12-21 11:46:22
Documents
15
Period of Report
2021-12-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20211220.htm   iXBRL 8-K 36696
2 EX-99.1 libervantfdanotification.htm EX-99.1 13353
6 GRAPHIC libervantfdanotification001.jpg GRAPHIC 355216
7 GRAPHIC libervantfdanotification002.jpg GRAPHIC 307818
  Complete submission text file 0001628280-21-025448.txt   1110672

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20211220.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20211220_lab.xml EX-101.LAB 24975
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20211220_pre.xml EX-101.PRE 13181
9 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20211220_htm.xml XML 11260
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 211507904
SIC: 2834 Pharmaceutical Preparations